Skip to content

Clinical trials

Phase 3 Lymphoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 3 Country / region: South Korea Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20132
20141
20151
20202
20212
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting6
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genmab2
Hoffmann-La Roche2
Janssen Research & Development, LLC2
Loxo Oncology, Inc.2
Acerta Pharma BV1
Bristol-Myers Squibb1
Celgene1
Novartis Pharmaceuticals1
Seagen Inc.1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma14
Lymphoma, Non-Hodgkin6
Lymphoma, B-Cell5
Lymphoma, Large B-Cell, Diffuse4
Hematologic Diseases3
Lymphoma, Follicular3
Neoplasms3
Hematologic Neoplasms1
Hodgkin Disease1
Leukemia, Lymphocytic, Chronic, B-Cell1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.